LYMPHOBLASTIC LYMPHOMA
Clinical trials for LYMPHOBLASTIC LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new LYMPHOBLASTIC LYMPHOMA trials appear
Sign up with your email to follow new studies for LYMPHOBLASTIC LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New 'Off-the-Shelf' cell therapy tested in patients with Hard-to-Treat blood cancers
Disease control CompletedThis study tested the safety and early effectiveness of a new type of CAR-T cell therapy called WU-CART-007 in adults and adolescents with T-cell leukemia or lymphoma that has returned or not responded to previous treatments. The therapy uses genetically modified immune cells fro…
Matched conditions: LYMPHOBLASTIC LYMPHOMA
Phase: PHASE1 • Sponsor: Wugen, Inc. • Aim: Disease control
Last updated Apr 04, 2026 03:05 UTC
-
Major trial tests tailored, intensive therapies to fight aggressive blood cancers
Disease control CompletedThis large study aimed to find the best treatment plans for adults newly diagnosed with acute lymphoblastic leukemia (ALL) or lymphoblastic lymphoma. It tested personalized, intensive chemotherapy approaches, including a specific drug (nelarabine) for a certain type of ALL, and e…
Matched conditions: LYMPHOBLASTIC LYMPHOMA
Phase: PHASE3 • Sponsor: Goethe University • Aim: Disease control
Last updated Mar 16, 2026 15:23 UTC